Intracerebroventricular STZ injection in mice culminates in cerebral glucose hypometabolism and various noxious effects via desensitization of insulin receptors in brain, leading to neurochemical alterations and cognitive decline reminiscent of AD in humans [23]. The gene discussed is INSR; the disease is Alzheimer disease.